TGM2
Basic information
Region (hg38): 20:38127385-38166578
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 16.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_004613.4 | NP_004604.2 | 13 | yes | - |
ENST00000361475.7 | ENSP00000355330.2 | 13 | yes | - |
NM_198951.3 | NP_945189.1 | 10 | - | - |
NM_001323316.2 | NP_001310245.1 | 13 | - | - |
Phenotypes
GenCC
Source:
- type 2 diabetes mellitus (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (95 variants)
- not_provided (31 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TGM2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_004613.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 14 | 12 | 26 | |||
| missense | 98 | 2 | 3 | 103 | ||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 4 | 4 | ||||
| Total | 0 | 0 | 103 | 16 | 15 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TGM2 | protein_coding | protein_coding | ENST00000361475 | 13 | 38118 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125626 | 0 | 122 | 125748 | 0.000485 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.536 | 400 | 431 | 0.927 | 0.0000299 | 4487 |
| Missense in Polyphen | 127 | 156.77 | 0.81011 | 1594 | ||
| Synonymous | -0.467 | 196 | 188 | 1.04 | 0.0000141 | 1336 |
| Loss of Function | 0.703 | 29 | 33.4 | 0.869 | 0.00000172 | 356 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000761 | 0.000757 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.000554 | 0.000554 |
| European (Non-Finnish) | 0.000330 | 0.000325 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.00158 | 0.00154 |
| Other | 0.000835 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the cross-linking of proteins and the conjugation of polyamines to proteins.;
- Pathway
- Huntington,s disease - Homo sapiens (human);phospholipase c delta in phospholipid associated cell signaling;Thromboxane A2 receptor signaling;Alpha9 beta1 integrin signaling events;Beta1 integrin cell surface interactions
(Consensus)
Recessive Scores
- pRec
- 0.707
Intolerance Scores
- loftool
- 0.248
- rvis_EVS
- -0.84
- rvis_percentile_EVS
- 11.48
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.962
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- blood vessel remodeling;isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine;negative regulation of endoplasmic reticulum calcium ion concentration;positive regulation of apoptotic process;positive regulation of I-kappaB kinase/NF-kappaB signaling;apoptotic cell clearance;positive regulation of cell adhesion;positive regulation of smooth muscle cell proliferation;positive regulation of inflammatory response;protein homooligomerization;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;positive regulation of mitochondrial calcium ion concentration;branching involved in salivary gland morphogenesis;salivary gland cavitation
- Cellular component
- mitochondrion;endoplasmic reticulum;cytosol;focal adhesion;intrinsic component of plasma membrane;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- protein-glutamine gamma-glutamyltransferase activity;protein binding;GTP binding;protein domain specific binding;metal ion binding